Paraquat (Gramoxone®) Parkinson’s class action certification upheld on appeal in British Columbia
Since 2021, Siskinds LLP has represented the plaintiffs in proposed paraquat (Gramoxone®) class actions across Canada, alleging that paraquat exposure is associated with an increased risk of developing Parkinson’s disease. These Canadian paraquat lawsuits allege that paraquat carries a serio…
View the post titled Paraquat (Gramoxone®) Parkinson’s class action certification upheld on appeal in British ColumbiaHow recent court rulings shape class action certification in British Columbia
If you are included in a class action that has been started in British Columbia, one of the first questions you likely have is whether the lawsuit will proceed. The answer depends on class action certification — a procedural step that determines whether a claim can move forward on behalf of …
View the post titled How recent court rulings shape class action certification in British ColumbiaClass action certification in British Columbia
Class actions are now a familiar part of the legal system in British Columbia. They allow people with similar legal claims to band together in a single lawsuit, making it possible to pursue cases that would be too expensive or complex to bring on an individual basis. In that sense, class act…
View the post titled Class action certification in British Columbia New consumer safeguards under British Columbia’s Business Practices and Consumer Protection Act
On March 31, 2025, British Columbia’s Bill 4 received Royal Assent, introducing several changes to the province’s Business Practices and Consumer Protection Act (the Act). Some of these amendments came into force immediately, while others will not be formally included in the Act until new re…
View the post titled New consumer safeguards under British Columbia’s Business Practices and Consumer Protection ActWhat British Columbia residents need to know about participating in class actions
As a Canadian, you have likely encountered news articles or other social media posts notifying you about ongoing or settled class actions. In recent years, you may have noticed that many of these class actions were commenced in British Columbia (BC). As a resident of British Columbia, you m…
View the post titled What British Columbia residents need to know about participating in class actionsClass action pursued concerning safety defects with GLP-1 drugs Mounjaro, Trulicity, & Zepbound
An application has been filed in Quebec to obtain authorization to institute a class action concerning the drugs Mounjaro, Trulicity, and Zepbound, alleging that the widely used diabetes and weight-loss medications may expose patients to serious health risks that were not adequately disclose…
View the post titled Class action pursued concerning safety defects with GLP-1 drugs Mounjaro, Trulicity, & ZepboundCancer-linked drug and product lawsuits: Legal pathways for affected patients
Patients who have been diagnosed with tumours or cancers after using pharmaceutical or health products may be able to pursue legal claims against manufacturers when credible scientific or regulatory evidence links those products to increased cancer risks. In such cases, product liability and…
View the post titled Cancer-linked drug and product lawsuits: Legal pathways for affected patientsTikTok faces privacy class action lawsuit for unauthorized data practices
Siskinds LLP and Rice Harbut Elliott LLP have commenced a proposed privacy class action in British Columbia against TikTok on behalf of persons in Canada, other than Quebec, who use or used the TikTok app between October 29, 2021 to the date of certification of the TikTok class action. This…
View the post titled TikTok faces privacy class action lawsuit for unauthorized data practicesHow to find the risks linked to your prescriptions
Does Mounjaro lead to stomach paralysis? What risks are associated with Xarelto blood thinner? Does Dupixent cause cancer? In recent years, Canadians have become increasingly concerned about the potential side effects of medications — from everyday prescriptions to vaccines to newer biologic…
View the post titled How to find the risks linked to your prescriptionsOzempic, a diabetes drug linked to gastrointestinal issues and vision loss, approved to treat kidney issues
Ozempic, a diabetes drug that has been the subject of multiple regulatory investigations due to its potential to expose users to serious health risks (including gastrointestinal issues and vision loss), has been approved to treat a new type of chronic health condition: kidney decline. Ozempi…
View the post titled Ozempic, a diabetes drug linked to gastrointestinal issues and vision loss, approved to treat kidney issuesReceive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.